Cargando…

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

SIMPLE SUMMARY: Rhabdomyosarcoma is the most common soft tissue cancer in children and adolescents. Its resemblance to skeletal muscle tissue distinguishes rhabdomyosarcomas from other types of soft tissue cancer. The development and integrity of healthy skeletal muscle depend on a strictly regulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pomella, Silvia, Danielli, Sara G., Alaggio, Rita, Breunis, Willemijn B., Hamed, Ebrahem, Selfe, Joanna, Wachtel, Marco, Walters, Zoe S., Schäfer, Beat W., Rota, Rossella, Shipley, Janet M., Hettmer, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216238/ https://www.ncbi.nlm.nih.gov/pubmed/37345159 http://dx.doi.org/10.3390/cancers15102823

Ejemplares similares

Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma
por: Regina, Carla, et al.
Publicado: (2021)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas
por: Missiaglia, Edoardo, et al.
Publicado: (2017)

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
por: O’Brien, Eleanor M., et al.
Publicado: (2018)

Epigenetic Deregulation of MicroRNAs in Rhabdomyosarcoma and Neuroblastoma and Translational Perspectives
por: Romania, Paolo, et al.
Publicado: (2012)

Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021)

Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
por: Manzella, Gabriele, et al.
Publicado: (2020)

Biological Role and Clinical Implications of MYOD1(L122R) Mutation in Rhabdomyosarcoma
por: Di Carlo, Daniela, et al.
Publicado: (2023)

Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2022)

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
por: Walters, Zoë S., et al.
Publicado: (2021)

Radioresistance in rhabdomyosarcomas: Much more than a question of dose
por: Camero, Simona, et al.
Publicado: (2022)

The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
por: Pomella, Silvia, et al.
Publicado: (2020)

The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells
por: Jaaks, Patricia, et al.
Publicado: (2016)

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2016)

DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
por: Camero, Simona, et al.
Publicado: (2021)

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
por: O’Brien, Eleanor, et al.
Publicado: (2023)

The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma
por: van Ewijk, Roelof, et al.
Publicado: (2021)

MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality
por: Rota, Rossella, et al.
Publicado: (2011)

Epigenetic Targets in Synovial Sarcoma: A Mini-Review
por: Hale, Ryland, et al.
Publicado: (2019)

MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015)

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
por: Gatz, Susanne A., et al.
Publicado: (2019)

Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
por: Gryder, Berkley E., et al.
Publicado: (2019)

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla, et al.
Publicado: (2016)

Epigenetic remodelling in human hepatocellular carcinoma
por: Braghini, Maria Rita, et al.
Publicado: (2022)

A combinatorial drug screen in PDX-derived primary rhabdomyosarcoma cells identifies the NOXA - BCL-XL/MCL-1 balance as target for re-sensitization to first-line therapy in recurrent tumors
por: Manzella, Gabriele, et al.
Publicado: (2021)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
por: Milton, Christopher I., et al.
Publicado: (2021)

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance
por: Danielli, Sara G., et al.
Publicado: (2023)

Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
por: Perrone, Clara, et al.
Publicado: (2023)

MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
por: Cassandri, Matteo, et al.
Publicado: (2021)

Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage
por: Gryder, Berkley E., et al.
Publicado: (2020)

Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells
por: De Salvo, Maria, et al.
Publicado: (2014)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022)

DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma
por: Virgone, Calogero, et al.
Publicado: (2015)

Lack of Electron Acceptors Contributes to Redox Stress and Growth Arrest in Asparagine-Starved Sarcoma Cells
por: Bauer, Christoph, et al.
Publicado: (2021)

Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
por: Maennlin, Simon, et al.
Publicado: (2022)

Growth inhibition associated with disruption of the actin cytoskeleton by Latrunculin A in rhabdomyosarcoma cells
por: Würtemberger, Julia, et al.
Publicado: (2020)

Primary orbital rhabdomyosarcoma with skeletal muscle metastasis
por: Das, Jayanta K., et al.
Publicado: (2010)

Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla D., et al.
Publicado: (2018)

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
por: Bonvini, P, et al.
Publicado: (2013)

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
por: Walters, Zoë S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5i1e2vt6i92ejdqbcf129lduus